Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

CRISPR/Cas9-modified hematopoietic stem cells—present and future perspectives for stem cell transplantation
Alberto Daniel-Moreno, Andrés Lamsfus‐Calle, Janani Raju, et al.
Bone Marrow Transplantation (2019) Vol. 54, Iss. 12, pp. 1940-1950
Open Access | Times Cited: 30

Showing 1-25 of 30 citing articles:

CRISPR-Cas Tools and Their Application in Genetic Engineering of Human Stem Cells and Organoids
Delilah Hendriks, Hans Clevers, Benedetta Artegiani
Cell stem cell (2020) Vol. 27, Iss. 5, pp. 705-731
Open Access | Times Cited: 137
Stimuli-responsive nanoformulations for CRISPR-Cas9 genome editing
Tianxu Fang, Xiaona Cao, Mysha Ibnat, et al.
Journal of Nanobiotechnology (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 31
Baboon Envelope Pseudotyped “Nanoblades” Carrying Cas9/gRNA Complexes Allow Efficient Genome Editing in Human T, B, and CD34+ Cells and Knock-in of AAV6-Encoded Donor DNA in CD34+ Cells
Alejandra Gutiérrez-Guerrero, Maria Jimena Abrey Recalde, Philippe Mangeot, et al.
Frontiers in Genome Editing (2021) Vol. 3
Open Access | Times Cited: 37
Therapy Development by Genome Editing of Hematopoietic Stem Cells
Lola Koniali, Carsten W. Lederer, Marina Kleanthous
Cells (2021) Vol. 10, Iss. 6, pp. 1492-1492
Open Access | Times Cited: 30
Humanized mice are precious tools for evaluation of hematopoietic gene therapies and preclinical modeling to move towards a clinical trial
Christian Brendel, Paula Rı́o, Els Verhoeyen
Biochemical Pharmacology (2019) Vol. 174, pp. 113711-113711
Open Access | Times Cited: 28
CRISPR medicine for blood disorders: Progress and challenges in delivery
Tahereh Mohammadian, Guillermo Ureña-Bailén, Yujuan Hou, et al.
Frontiers in Genome Editing (2023) Vol. 4
Open Access | Times Cited: 9
Localized immunomodulation technologies to enable cellular and organoid transplantation
Amanda Nash, Nienke Lokhorst, Omid Veiseh
Trends in Molecular Medicine (2023) Vol. 29, Iss. 8, pp. 635-645
Open Access | Times Cited: 9
Genome Editing-Mediated Utrophin Upregulation in Duchenne Muscular Dystrophy Stem Cells
Kasturi Sengupta, Manoj K. Mishra, Emanuele Loro, et al.
Molecular Therapy — Nucleic Acids (2020) Vol. 22, pp. 500-509
Open Access | Times Cited: 22
Automated Good Manufacturing Practice-Compatible CRISPR-Cas9 Editing of Hematopoietic Stem and Progenitor Cells for Clinical Treatment of β-Hemoglobinopathies
Guillermo Ureña-Bailén, Milena Block, Tommaso Grandi, et al.
The CRISPR Journal (2023) Vol. 6, Iss. 1, pp. 5-16
Open Access | Times Cited: 7
Hematopoietic stem cell gene therapy: The optimal use of lentivirus and gene editing approaches
Andrés Lamsfus‐Calle, Alberto Daniel-Moreno, Guillermo Ureña-Bailén, et al.
Blood Reviews (2019) Vol. 40, pp. 100641-100641
Closed Access | Times Cited: 20
Nogo receptor-Fc delivered by haematopoietic cells enhances neurorepair in a multiple sclerosis model
Sining Ye, Paschalis Theotokis, Jae Young Lee, et al.
Brain Communications (2023) Vol. 5, Iss. 2
Open Access | Times Cited: 6
CRISPR/Cas9 technology: towards a new generation of improved CAR-T cells for anticancer therapies
Guillermo Ureña-Bailén, Andrés Lamsfus‐Calle, Alberto Daniel-Moreno, et al.
Briefings in Functional Genomics (2019) Vol. 19, Iss. 3, pp. 191-200
Closed Access | Times Cited: 17
A Mutation-Agnostic Hematopoietic Stem Cell Gene Therapy for Metachromatic Leukodystrophy
Justin S. Antony, Alberto Daniel-Moreno, Andrés Lamsfus‐Calle, et al.
The CRISPR Journal (2021) Vol. 5, Iss. 1, pp. 66-79
Closed Access | Times Cited: 11
Pediatric Bone Marrow Failure: A Broad Landscape in Need of Personalized Management
Lotte Vissers, Mirjam van der Burg, Arjan C. Lankester, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 22, pp. 7185-7185
Open Access | Times Cited: 4
Utilization of CRISPR/Cas9 gene editing in cellular therapies for lymphoid malignancies
Maryam Mehravar, Elham Roshandel, Maryam Salimi, et al.
Immunology Letters (2020) Vol. 226, pp. 71-82
Closed Access | Times Cited: 10
Selecting a Cell Engineering Methodology During Cell Therapy Product Development
Lauren M. Timmins, Alexandra Burr, Kristina Carroll, et al.
Cell Transplantation (2021) Vol. 30
Open Access | Times Cited: 8
The research on the treatment of primary immunodeficiency diseases by hematopoietic stem cell transplantation: A bibliometric analysis from 2013 to 2022
Siqi Hu, Shixia Xu, Wei Lü, et al.
Medicine (2023) Vol. 102, Iss. 13, pp. e33295-e33295
Open Access | Times Cited: 3
CRISPR-Cas9 based genome editing for defective gene correction in humans and other mammals
Janardhan Keshav Karapurkar, Ainsley Mike Antao, Kye-Seong Kim, et al.
Progress in molecular biology and translational science (2021), pp. 185-229
Closed Access | Times Cited: 7
Therapeutic targeting and HSC proliferation by small molecules and biologicals
Esra Albayrak, Fatih Kocabaş
Advances in protein chemistry and structural biology (2023), pp. 425-496
Closed Access | Times Cited: 2
Hematopoietic Stem Cell-Based Platelet-Targeted Gene Therapy for Hemophilia
Qizhen Shi
Elsevier eBooks (2024), pp. 406-418
Closed Access
CRISPR-CAS9-MEDIATED EX VIVO GENE EDITING FOR INHERITED HEMATOLOGICAL DISORDERS: ADVANCEMENTS, CHALLENGES, AND CLINICAL POTENTIAL
A. R. Panda, S.R. Das
International Journal of Pharmacy and Pharmaceutical Sciences (2024), pp. 1-7
Open Access
Comparative analysis of lentiviral gene transfer approaches designed to promote fetal hemoglobin production for the treatment of β-hemoglobinopathies
Alberto Daniel-Moreno, Andrés Lamsfus‐Calle, Andrew Wilber, et al.
Blood Cells Molecules and Diseases (2020) Vol. 84, pp. 102456-102456
Closed Access | Times Cited: 3
Commentary: Organ ARCs: Assessment and repair centers in transplantation as gateways to meaningful therapeutic interventions
Bryan A. Whitson, Sylvester M. Black
JTCVS Open (2020) Vol. 3, pp. 173-174
Open Access | Times Cited: 3
Stem Cell Therapy for the Treatment of Crohn's Disease; Current Obstacles and Future Hopes
Sarah El-Nakeep
Current Stem Cell Research & Therapy (2021) Vol. 17, Iss. 8, pp. 727-733
Closed Access | Times Cited: 3
Graft‐Versus‐Tumor Effect in Major Histocompatibility Complex–Mismatched Mouse Liver Transplantation
Dongdong Yu, Lidong Wang, Tianchun Wu, et al.
Liver Transplantation (2019) Vol. 25, Iss. 8, pp. 1251-1264
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top